Allient
ALNT
113.33
-3.91
-3.34%
Allient
US · ALNT
#2774 by market cap
Listed 1970
113.33
-3.91
-3.34%
Live - 5344 symbols - heartbeat 53s ago
· 2026-10-08 07:23
Pre-market
110.90
-2.14%
After-hours
113.33
0.00%
- Market cap
- 1.93B
- P/E (TTM)i
- 66.66
- P/Bi
- 6.17
- EPSi
- 1.32
- Div yieldi
- 0.11%
- 52W posi
- 90%
Reader sentiment
Are you bullish or bearish on ALNT?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 6.28, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +4.62% YoY
Margins
- Gross margin
- 32.77%
- Operating margin
- 8.66%
- Net margin
- 3.97%
Key ratios & quality
- Enterprise valuei
- 2.06B
- PEG ratioi
- 8.12
- Altman Z-Scorei
- 6.28
PEG uses trailing P/E against the 3-year net income growth rate (8.21%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG." Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 310.61M | 371.08M | 366.69M | 403.52M | 502.99M | 578.63M | 529.97M | 554.48M |
| Gross profit | 91.40M | 112.58M | 108.58M | 121.06M | 157.26M | 183.68M | 165.69M | 181.71M |
| Selling & admin expenses | 43.84M | 54.22M | 53.69M | 59.67M | 72.55M | 83.12M | 80.98M | 82.38M |
| Research & development | 19.91M | 23.09M | 25.49M | 27.82M | 38.56M | 41.67M | 39.76M | 38.84M |
| Operating profit | 23.23M | 29.44M | 22.99M | 26.03M | 31.66M | 42.31M | 32.45M | 48.03M |
| Pretax profit | 20.68M | 23.84M | 18.78M | 23.11M | 23.68M | 29.70M | 16.86M | 28.73M |
| Tax | 4.76M | 6.82M | 5.13M | -981.00K | 6.29M | 5.60M | 3.69M | 6.70M |
| Net profit | 15.93M | 17.02M | 13.64M | 24.09M | 17.39M | 24.10M | 13.17M | 22.03M |
| Basic EPS | 1 | 1 | 1 | 2 | 1 | 2 | 1 | 1 |
| Diluted EPS | 1.13 | 1.20 | 0.95 | 1.66 | 1.09 | 1.48 | 0.79 | 1.32 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 132.80M | 139.58M | 138.74M | 143.35M | 138.92M | 153.77M |
| Gross profit | 42.75M | 46.36M | 46.18M | 46.42M | 45.38M | 53.59M |
| Selling & admin expenses | 19.83M | 20.47M | 20.33M | 21.76M | 22.43M | 23.52M |
| Research & development | 9.55M | 9.94M | 9.69M | 9.65M | 9.64M | 10.68M |
| Operating profit | 10.28M | 12.82M | 13.03M | 11.89M | 10.18M | 16.25M |
| Pretax profit | 4.46M | 7.30M | 8.32M | 8.65M | 6.78M | 13.02M |
| Tax | 903.00K | 1.69M | 1.85M | 2.27M | 1.43M | 2.63M |
| Net profit | 3.56M | 5.62M | 6.48M | 6.38M | 5.36M | 10.39M |
| Basic EPS | 0 | 0 | 0 | 0 | 0 | 1 |
| Diluted EPS | 0.21 | 0.34 | 0.39 | 0.38 | 0.32 | 0.61 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 110.89M | 115.64M | 142.21M | 175.96M | 236.01M | 248.15M | 237.58M | 253.44M |
| Cash & ST investments | 8.67M | 13.42M | 23.13M | 22.46M | 30.61M | 31.90M | 36.10M | 40.71M |
| Inventory | 54.97M | 53.39M | 62.98M | 89.73M | 117.11M | 117.69M | 111.52M | 109.20M |
| Total assets | 285.30M | 305.83M | 349.20M | 470.79M | 588.35M | 597.54M | 575.78M | 577.60M |
| Total current liabilities | 44.59M | 46.64M | 52.53M | 78.37M | 87.59M | 95.62M | 57.38M | 69.32M |
| Short-term debt | -- | 3.20M | 4.67M | 4.53M | 4.60M | 5.55M | 5.54M | 5.81M |
| Long-term debt | 122.52M | 109.77M | 120.08M | 158.96M | 226.44M | 209.80M | 216.02M | 172.62M |
| Total liabilities | 183,488,000.00 | 186,634,000.00 | 206,141,000.00 | 283,023,000.00 | 372,882,000.00 | 345,967,000.00 | 310,927,000.00 | 276,140,000.00 |
| Total equity | 101.81M | 119.19M | 143.06M | 187.76M | 215.47M | 251.58M | 264.85M | 301.46M |
| Retained earnings | 76.72M | 92.59M | 105.07M | 127.76M | 143.58M | 165.81M | 177.01M | 197.05M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 253.87M | 253.94M | 258.06M | 253.44M | 259.53M | 274.45M |
| Cash & ST investments | 47.75M | 49.92M | 39.48M | 40.71M | 41.18M | 42.09M |
| Inventory | 105.57M | 106.55M | 111.36M | 109.20M | 110.13M | 117.91M |
| Total assets | 586.90M | 588.06M | 585.08M | 577.60M | 577.66M | 593.92M |
| Total current liabilities | 63.07M | 67.82M | 73.03M | 69.32M | 69.62M | 80.18M |
| Short-term debt | 5.64M | 5.84M | 5.84M | 5.81M | 5.63M | 5.98M |
| Long-term debt | 214.16M | 194.30M | 182.46M | 172.62M | 169.79M | 165.95M |
| Total liabilities | 314,071,000.00 | 299,002,000.00 | 290,911,000.00 | 276,140,000.00 | 271,737,000.00 | 281,627,000.00 |
| Total equity | 272.83M | 289.06M | 294.17M | 301.46M | 305.93M | 312.29M |
| Retained earnings | 180.05M | 185.19M | 191.16M | 197.05M | 201.90M | 211.62M |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 17.45M | 34.53M | 24.84M | 25.40M | 5.60M | 45.04M | 41.85M | 56.68M |
| Depreciation & amortization | 11.58M | 14.86M | 15.99M | 18.11M | 25.49M | 25.07M | 25.89M | 25.41M |
| Free cash flow | 3.12M | 19.65M | 15.47M | 11.69M | -10.31M | 33.44M | 32.17M | 49.69M |
| Dividends paid | -1.08M | -1.17M | -1.16M | -1.37M | -1.54M | -1.83M | -1.98M | -2.00M |
| Stock buybacks / issuance | -- | -- | -- | -- | -- | -- | -- | -- |
| Ending cash balance | 8.67M | 13.42M | 23.13M | 22.46M | 30.61M | 31.90M | 36.10M | 40.71M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 13.93M | 24.51M | 4.68M | 13.56M | 6.17M | 13.95M |
| Depreciation & amortization | 6.28M | 6.40M | 6.42M | 6.30M | 6.21M | 6.19M |
| Free cash flow | 12.87M | 22.38M | 2.78M | 11.66M | 4.01M | 9.05M |
| Dividends paid | -- | -- | -501.00K | -500.00K | -- | -- |
| Stock buybacks / issuance | -- | -- | -- | -- | -- | -- |
| Ending cash balance | 47.75M | 49.92M | 39.48M | 40.71M | 41.18M | 42.09M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 16.84 | 15.40 | 10.40 | 14.57 | 8.62 | 10.32 | 5.10 | 7.78 |
| ROA %i | 6.73 | 5.76 | 4.17 | 5.88 | 3.28 | 4.06 | 2.24 | 3.82 |
| ROIC %i | 9.88 | 8.74 | 6.18 | 8.18 | 5.50 | 7.04 | 4.67 | 6.31 |
| 5-year avg ROE %i | 17.04 | 14.79 | 13.20 | 13.46 | 13.17 | 11.86 | 9.80 | 9.28 |
| EBIT margin %i | 7.53 | 7.81 | 6.13 | 6.53 | 6.24 | 7.27 | 5.69 | 7.56 |
| FCF / sales %i | 1.00 | 5.29 | 4.22 | 2.90 | -- | 5.78 | 6.07 | 8.96 |
| Current ratioi | 2.49 | 2.48 | 2.71 | 2.25 | 2.69 | 2.60 | 4.14 | 3.66 |
| Quick ratioi | 1.16 | 1.24 | 1.34 | 0.94 | 1.22 | 1.22 | 2.00 | 1.87 |
| Debt / assetsi | 42.94 | 41.42 | 40.01 | 37.44 | 44.00 | 40.75 | 43.27 | 35.08 |
| LT debt / equityi | 120.33 | 103.60 | 94.41 | 91.47 | 118.00 | 94.58 | 91.97 | 65.29 |
| Interest coveragei | 8.66 | 5.64 | 6.05 | 8.14 | 4.08 | 3.40 | 2.27 | 3.18 |
| Revenue CAGR (3Y) %i | 10.15 | 14.70 | 13.32 | 9.11 | 10.67 | 16.42 | 9.51 | 3.30 |
| Net income CAGR (3Y) %i | 12.87 | 23.31 | 19.30 | 14.80 | 0.71 | 20.88 | -18.24 | 8.21 |
| FCF CAGR (3Y) %i | -41.20 | 29.18 | -6.96 | 55.32 | -- | 29.30 | 40.15 | -- |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 3.64 | 5.15 | 6.58 | 7.78 | 8.24 | 9.51 |
| ROA %i | 1.64 | 2.41 | 3.16 | 3.82 | 4.09 | 4.84 |
| ROIC %i | 3.89 | 4.79 | 5.66 | 6.31 | 6.47 | 7.26 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 5.05 | 6.17 | 7.06 | 7.56 | 7.70 | 8.32 |
| FCF / sales %i | 7.52 | 10.66 | 8.94 | 8.96 | 7.28 | 4.78 |
| Current ratioi | 4.03 | 3.74 | 3.53 | 3.66 | 3.73 | 3.42 |
| Quick ratioi | 2.15 | 1.99 | 1.80 | 1.87 | 1.91 | 1.77 |
| Debt / assetsi | 42.07 | 38.56 | 36.50 | 35.08 | 34.29 | 33.28 |
| LT debt / equityi | 88.43 | 76.42 | 70.62 | 65.29 | 62.90 | 61.37 |
| Interest coveragei | 1.92 | 2.34 | 2.75 | 3.18 | 3.57 | 4.32 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
Revenue breakdown most recent period
Business
Manufacture and marketing of specialty-controlled motion products and solutions for end user and100.00%
Quote time 2026-10-08 07:23:53 · For reference only, not investment advice and not tailored to your situation.